Jump to page content Accessibility
News, views and contacts from the global Drugdevelopment industry
Login to drugdevelopment-technology.com Log in or Register
  • Home
  • Products & Services
  • Company A - Z
  • Projects
  • Features
  • Videos
  • White Papers
  • News
  • Events
  • Advertise With Us
Industry Projects | Projects by Region | Projects by Category | Archived Projects | Project Gallery
 

Yervoy (Ipilimumab) - Therapy for Treatment of Metastatic Melanoma, United States of America



Yervoy works by binding or inhibiting CTLA-4.


  • Yervoy is the first drug approved for treating metastatic melanoma.

  • Melanoma is a type of skin cancer.

  • Yervoy works by binding or inhibiting CTLA-4.

Back to Project Details



Related Projects

Fablyn (Lasofoxifene) - Investigational SERM
The product of a joint development programme between Pfizer and...

Naproxcinod (HCT 3012) - COX-Inhibiting Nitric Oxide-Donator
Developed by French pharmaceutical company NicOx, naproxcinod (HCT 3012)...

Rupintrivir -
Agouron Pharmaceuticals, a subsidiary of Pfizer, has pioneered...

Tarceva - Small Molecule
Tarceva (erlotinib) is an oral anti-cancer drug developed by...

Acomplia (Rimonabant) - Investigational Agent for
Developed by Sanofi-Aventis, Acomplia (rimonabant) is a selective...

See all projects


Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

drugdevelopment-technology.com is a product of Net Resources International. Copyright 2011 Net Resources International, a trading division of SPG Media Limited.